Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.
Meissner EG, Wu D, Osinusi A, Bon D, Virtaneva K, Sturdevant D, Porcella S, Wang H, Herrmann E, McHutchison J, Suffredini AF, Polis M, Hewitt S, Prokunina-Olsson L, Masur H, Fauci AS, Kottilil S. Meissner EG, et al. Among authors: virtaneva k. J Clin Invest. 2014 Aug;124(8):3352-63. doi: 10.1172/JCI75938. Epub 2014 Jul 1. J Clin Invest. 2014. PMID: 24983321 Free PMC article. Clinical Trial.
Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.
Meissner EG, Kohli A, Virtaneva K, Sturdevant D, Martens C, Porcella SF, McHutchison JG, Masur H, Kottilil S. Meissner EG, et al. Among authors: virtaneva k. J Viral Hepat. 2016 Jul;23(7):496-505. doi: 10.1111/jvh.12510. Epub 2016 Feb 3. J Viral Hepat. 2016. PMID: 26840694 Free PMC article. Clinical Trial.
Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial.
Meissner EG, McLaughlin M, Matthews L, Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D, Martens C, Porcella SF, Goodman ZD, Kanwar B, Myers RP, Subramanian M, Hadigan C, Masur H, Kleiner DE, Heller T, Kottilil S, Kovacs JA, Morse CG. Meissner EG, et al. Among authors: virtaneva k. Liver Int. 2016 Dec;36(12):1783-1792. doi: 10.1111/liv.13177. Epub 2016 Jul 6. Liver Int. 2016. PMID: 27232579 Free PMC article. Clinical Trial.
miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation.
Kelada S, Sethupathy P, Okoye IS, Kistasis E, Czieso S, White SD, Chou D, Martens C, Ricklefs SM, Virtaneva K, Sturdevant DE, Porcella SF, Belkaid Y, Wynn TA, Wilson MS. Kelada S, et al. Among authors: virtaneva k. PLoS Pathog. 2013;9(6):e1003451. doi: 10.1371/journal.ppat.1003451. Epub 2013 Jun 27. PLoS Pathog. 2013. PMID: 23825948 Free PMC article.
Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.
Greenberg DE, Shoffner AR, Zelazny AM, Fenster ME, Zarember KA, Stock F, Ding L, Marshall-Batty KR, Wasserman RL, Welch DF, Kanakabandi K, Sturdevant DE, Virtaneva K, Porcella SF, Murray PR, Malech HL, Holland SM. Greenberg DE, et al. Among authors: virtaneva k. Emerg Infect Dis. 2010 Sep;16(9):1341-8. doi: 10.3201/eid1609.091800. Emerg Infect Dis. 2010. PMID: 20735916 Free PMC article.
Host-microbe interaction systems biology: lifecycle transcriptomics and comparative genomics.
Sturdevant DE, Virtaneva K, Martens C, Bozinov D, Ogundare O, Castro N, Kanakabandi K, Beare PA, Omsland A, Carlson JH, Kennedy AD, Heinzen RA, Celli J, Greenberg DE, DeLeo FR, Porcella SF. Sturdevant DE, et al. Among authors: virtaneva k. Future Microbiol. 2010 Feb;5(2):205-19. doi: 10.2217/fmb.09.125. Future Microbiol. 2010. PMID: 20143945 Free PMC article. Review.
63 results